Testimonials

What Our Customers Say

“As a mid-sized biopharmaceutical company, we can maximize the value we create for patients by working with partners who effectively extend our reach. Such is the case working with Pharma To Market who has delivered a product registration in Singapore each year since we started our partnership.  Pharma to Market works independently with consistency – allowing my in-house team to focus on essential internal collaboration and strategic decision-making.  This professionalism builds trust, so when we needed to have Pharma to Market manage product registration in a third country that we did not yet have a significant presence ourselves, it gave us complete peace of mind.”
Boon Heon Tan
UCB, Asia Pacific Rim & India

“Pharma To Market have been with Radiometer S.E.A Pte Ltd for many years, working with our different overseas teams. Despite the nature of our medical devices – IVDs with multiple models and with constantly upgraded software, their consultants are always available to help with any of our regulatory requests. Providing meticulous and responsive feedback that are supportive towards our business operations. I would strongly and wholeheartedly recommend Pharma To Market as an extremely competent regulatory consultancy.”
Ling Ming Yao
Radiometer S.E.A Pte. Ltd, Singapore

“Pharma To Market is a trusted service provider that addresses our needs from registration to quality conformance and is supporting us with a diverse set of needs for our products. The support from Pharma To Market is always quick and their advice always clear. Their leadership in consultancy across multiple avenues makes them a superior partner and we look forward to our partnership growing even further.”
Heraeus Medical, Germany

“Pharma To Market clearly understands our needs and works towards gathering and analysing regulatory requirements, providing excellent regulatory advice which can be utilised commercially. I was also very impressed with the professionalism and industry expertise demonstrated by their team for product registrations in the ASEAN countries. Flexible with client needs and responsive, they accomplished the submissions always in time to achieve the various project milestones.”

Takayuki Nagatsuka
Nissan Chemical Corporation, Japan

“We chose to work with Pharma To Market to register our products and the experience was excellent. Pharma To Market provided an insightful overview of the registration requirements to aid our understanding of the process. They also took initiatives to identify potential areas of concern. The result was less time spent on the registrations and that allowed us to promptly and efficiently place our brands on the local market.”
Vladimir Ilievski
AFT Pharmaceuticals Limited, New Zealand

“The (Authoring eCTD Compliant Documents) workshop was an excellent overview of the documentation requirements for NeeS/eCTD submissions. The ‘hands on’ part of the training highlighted many features within Microsoft Word and Adobe Acrobat which will assist us in producing compliant documentation efficiently in preparation for future eCTD submissions in Australia.”
Dr Danielle McLennan
Generic Partners Pty Ltd, Australia

“Pharma To Market were extremely efficient in providing the NeeS version of a Module 1 related to a Product information update when IT support was not available from the corporate HQ of a local client. Pharma To Market responded to meet a very tight deadline and were very professional to work with.”
Anne O’Shea
O’Shea and Associates Pty Ltd, Australia

“The one day (Authoring eCTD Compliant Documents) workshop was run very professionally. All the information provided was relevant and current. There was a very good balance of theory and practical exercises. The take home resources, including the educational workshop guide and the preformatted template continue to be of great help in the day-to-day work of writing and formatting the Modules. From a personal perspective, I have greatly appreciated the continued assistance from the Pharma To Market team in authoring publishable Modules.”
Gabrijela Matanovic
Phebra Pty Ltd, Australia

“I have had the pleasure of working with Pharma To Market for the last 18 months preparing a particularly challenging regulatory submission for a large multinational pharmaceutical company. Johanna and Nick demonstrated excellent Australian regulatory expertise, providing strong direction and displaying outstanding organizational skills which resulted in the production of a high quality submission within a tight deadline. They have always remained focused and professional and were willing to go the extra mile to complete the task at hand. I would not hesitate to recommend Pharma To Market for their regulatory affairs services and hope that I have the opportunity to work with them in the future.”
Francis Upchurch BSc MB ChB DRCOG FFPM
PharmDoc Limited, United Kingdom

“Pharma To Market has been pivotal in kicking off our market entry, providing us with strategic guidance and helping us to obtain confirmation on the classifications of our range of supplement products, many of which fall into borderline categories. They had delivered prompt service and clarity in this project which enabled us to proceed to market launch quickly. I have no hesitation in recommending their services.”
Antoni Watts
Intelligent Labs (RAD ONE LTD), United Kingdom

“The quality and pharmacovigilance training delivered by Pharma To Market was exactly what we needed and more. The level of knowledge of trainers were excellent. The material was highly relevant to our roles and the trainers were flexible in their teaching, tailoring the programme and providing examples to reinforce our understanding. We came away with valuable new techniques that we can implement into our quality management system and our drug safety activities to ensure that we remain compliant in this strictly regulated industry.”
Joyce Ooi
Vifor Pharma, Asia Pacific

“The customised training sessions organised by Pharma To Market were very insightful and helpful to our work. The experienced consultants provided useful tips and were thorough and patient in answering of questions. After the training, we were able to make sense of the nuances of entering another new market and communicate with our internal stakeholders in a better manner. I would not hesitate to recommend Pharma To Market to other companies in the same field.”
RA Department
Otsuka Pharmaceuticals, Singapore

“The Pharmaceutical Regulatory Affairs and Pharmacovigilance Asia Workshop organised by Pharma To Market was very informative. The workshop met my objectives and I especially enjoyed the interesting segments on Lifecycle Management and Innovation in RA . I came away with valuable new ideas on how to operate in this dynamic industry with ever-changing regulations and I would definitely recommend this workshop to my friends and colleagues.”
Inhye Kim
Otsuka Pharmaceuticals, Singapore

“I was looking for someone who could convert my non-electronic Active Substance Master File to eCTD format and submit it to the relevant regulatory authorities in only ten days. After my initial phone conversation with Nick, I was confident that they were capable of doing the work, the only question is my mind was the extremely tight deadline. However, Nick committed to meeting the target and the eCTD formatted ASMF was submitted on time and accepted by the authority. Their fast response to my needs effectively saved our client’s marketing authorization application from being pipped at the post by a competitor.

Subsequently, Pharma To Market have supported the submission through all stages of approval by the authority, giving sound advice when needed and always meeting tight deadlines. The marketing authorization has now been granted.

Pharma To Market have continued providing solid service for the other projects we have since engaged them on and we look forward to continuing our positive association.”
Dennis Hucker
New Zealand Pharmaceuticals Ltd, New Zealand